A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945
Status:
Completed
Trial end date:
2018-04-27
Target enrollment:
Participant gender:
Summary
PC945 is a new medicine being developed for treatment of fungal lung diseases. The main
purpose of this study is to investigate the safety, tolerability and pharmacokinetics of
single and repeat doses of PC945